Opinion

Hantavirus, the WHO, and the Conflicts in Weighing Mortality

Google LogoMark Us Preferred on Google
Hantavirus, the WHO, and the Conflicts in Weighing Mortality
A general view of the cruise ship MV Hondius, while stationary off the port of Praia, the capital of Cape Verde, on May 6, 2026. AFP via Getty Images
David Bell
|Updated:
0:00
Commentary
Yesterday, almost 2,000 people, mostly young children, died of malaria because they could not access effective and relatively cheap treatment quickly enough. About 4,000 people died of tuberculosis (TB), including many young adults leaving orphans. This happens every day. Progress in reducing these numbers is stalling, as partly due to the continuing economic damage from the COVID-19 response.
Google LogoMark Us Preferred on Google
David Bell
David Bell
Author
David Bell, senior scholar at the Brownstone Institute, is a public health physician and biotech consultant in global health. He is a former medical officer and scientist at the World Health Organization (WHO), programme head for malaria and febrile diseases at the Foundation for Innovative New Diagnostics (FIND) in Geneva, Switzerland, and director of Global Health Technologies at Intellectual Ventures Global Good Fund in Bellevue, Wash.
twitter